Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

Satisfaction study of split doses botulinum toxin with double frequency Recruiting

2025-520915-14-00 Wrinkles, fine lines 10 2023-01-12
A Phase 3 Study to Investigate the Efficacy and Safety of Brepocitinib in Adults with Dermatomyositis Recruiting

2022-500367-12-00 Dermatomyositis 5 2022-11-30
Medical-scientific research into a new own skin graft product (EHSG-KF) Recruiting

2024-512189-33-00 Children with partial deep dermal and full thickness bu 4 2019-01-14
Dose Ranging Study of ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis (EVERLAST-B) Recruiting

2025-523797-17-00 Moderate-to-Severe Plaque Psoriasis 4 2026-05-08
A first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune medi… Recruiting

2026-525575-22-00 Psoriasis 1 2026-05-07
A Pragmatic Randomized Trial to Evaluate the Effect of Recombinant Herpes Zoster Vaccine on Major Adverse Cardiovascular Events and Dementia… Recruiting

2025-524944-37-00 Herpes Zoster 6 2026-04-28
A Phase 3 Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less… Recruiting

2025-522567-15-00 Plaque Psoriasis 5 2026-04-28
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa Recruiting

2025-522440-41-00 Hidradenitis Suppurativa 4 2026-04-27
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medic… Recruiting

2025-522705-37-00 HIDRADENITIS SUPPURATIVA 4 2026-04-21
A study to assess NAV-240 in adult participants with Hidradenitis Suppurativa Recruiting

2025-523557-33-00 Moderate-to-Severe Hidradenitis Suppurativa 4 2026-04-20
A Phase 2 Study of Lesigercept (YH35324) in Adult Patients with Chronic Spontaneous Urticaria (CLEAR) Recruiting

2025-524006-14-00 Chronic Spontaneous Urticaria 4 2026-04-20
Phase 3 Study of Barzolvolimab in Participants with Cold Induced Urticaria and Symptomatic Dermographism Recruiting

2025-522583-32-00 Cold-Induced Urticaria and Symptomatic Dermographism 5 2026-04-13
Phase 3 Efficacy and Safety of Lebrikizumab in Adults With Nummular Eczema (LUMINE) Recruiting

2025-522403-17-00 Nummular Dermatitis 5 2026-04-10
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 Recruiting

2025-521973-16-00 Netherton Syndrome 9 2026-03-31
A study to learn if galvokimig is safe and works in adults with moderate to severe atopic dermatitis Recruiting

2025-522578-35-00 Atopic Dermatitis 4 2026-03-30
Topical delgocitinib for facial vitiligo Recruiting

2025-523635-19-00 Vitiligo 4 2026-03-25
A Study to Learn About the Study Medicine Called Ritlecitinib in People With Hives Without a Known Cause Recruiting

2025-522642-44-00 CHRONIC SPONTANEOUS URTICARIA 4 2026-03-18
Changes in the wound microbiome and their impact on chronic wound healing under hyperbaric conditions Recruiting

2025-523863-39-00 chronic wounds 6 2026-03-05
The effect of anifrolumab on cutaneous lupus erythematosus characterized by the change of the inflammatory infiltrate analyzed by immunohist… Recruiting

2025-523133-26-00 cutaneous lupus erythematosus 6 2026-02-12
Clinical trial of VDA-1102 ointment for patients with actinic keratosis Recruiting

2025-522482-30-00 Actinic keratosis 4 2026-02-11
A Study to Assess the Long-Term Efficacy and Safety of Afimkibart (RO7790121) in Patients with Atopic Dermatitis who participated in previou… Recruiting

2025-520771-59-00 Atopic Dermatitis 4 2026-02-03
A Study of KT-621 Administered Orally to Participants with Moderate to Severe Atopic Dermatitis (BROADEN2) Recruiting

2025-522370-36-00 Moderate to Severe Atopic Dermatitis 4 2026-02-02
Efficacy and safety of two moisturising creams for maintenance treatment of atopic dermatitis Recruiting

2025-521620-29-01 Atopic Dermatitis 4 2026-01-26
A multi-part, adaptive, Phase 1, first time in human study in healthy participants and participants with atopic dermatitis (AD) to assess th… Recruiting

2025-522216-17-00 Atopic Dermatitis 1 2026-01-26